Search

Your search keyword '"Thuy Le Md"' showing total 4 results
Start Over Author "Thuy Le Md"
4 results on '"Thuy Le Md"'

1. Imaging characteristics of posterior interosseous nerve syndrome

Author

Ho Xuan Tuan, MD, PhD, Hoang Tu Minh, MD, Nguyen-Van Cong, MD, Ma Mai Hien, MD, Van Thuy Le, MD, Nguyen Duy Hung, MD, and Nguyen Minh Duc, MD

Subjects
Posterior interosseous nerve syndrome, Nerve compression syndrome, PINs, Arcade of Frohse, Medical physics. Medical radiology. Nuclear medicine, R895-920
Abstract

Posterior interosseous nerve syndrome (PINs) is a rare nerve compression syndrome that affects the deep branch of the radial nerve in the supinator muscle region. In this article, we aimed to report a case of a 58-year-old male who had clinical symptoms, electromyographic, ultrasound, and MRI features suggestive of PINs due to compressing the arcade of Frohse. He subsequently underwent surgical correlation at our hospital, and the clinical symptoms were improved significantly.

Published
2024
Full Text
View/download PDF

2. A global call for talaromycosis to be recognised as a neglected tropical disease

Author

Shanti Narayanasamy, MBBS, Vu Quoc Dat, MD, Nguyen Tat Thanh, MD, Vo Trieu Ly, MD, Jasper Fuk-Woo Chan, MD, Kwok-Yung Yuen, MD, Chuanyi Ning, MD, Hao Liang, MD, Linghua Li, MD, Anuradha Chowdhary, MD, Sirida Youngchim, PhD, Khuanchai Supparatpinyo, MD, Ne Myo Aung, MD, Josh Hanson, MBBS, Alex Andrianopoulos, PhD, John Dougherty, MD, Nelesh P Govender, ProfMBBCh, David W Denning, ProfFRCP, Tom Chiller, MD, Guy Thwaites, ProfMD, H Rogier van Doorn, ProfMD, John Perfect, ProfMD, and Thuy Le, MD

Subjects
Public aspects of medicine, RA1-1270
Abstract

Summary: Talaromycosis (penicilliosis) is an invasive mycosis that is endemic in tropical and subtropical Asia. Talaromycosis primarily affects individuals with advanced HIV disease and other immunosuppressive conditions, and the disease disproportionally affects people in low-income and middle-income countries, particularly agricultural workers in rural areas during their most economically productive years. Approximately 17 300 talaromycosis cases and 4900 associated deaths occur annually. Talaromycosis is highly associated with the tropical monsoon season, when flooding and cyclones can exacerbate the poverty-inducing potential of the disease. Talaromycosis can present as localised or disseminated disease, the latter causing cutaneous lesions that are disfiguring and stigmatising. Despite up to a third of diagnosed cases resulting in death, talaromycosis has received little attention and investment from regional and global funders, policy makers, researchers, and industry. Diagnostic and treatment modalities remain extremely insufficient, however control of talaromycosis is feasible with known public health strategies. This Viewpoint is a global call for talaromycosis to be recognised as a neglected tropical disease to alleviate its impact on susceptible populations.

Published
2021
Full Text
View/download PDF

3. 30-day readmission prevention program in heart failure patients (RAP-HF) in a community hospital: creating a task force to improve performance in achieving CMS target goals

Author

Shuaib Rabbani, Wajiah Illyas, Haseeb Siddique, Joan Faro, Phyllis Macchio, Alan Kaell, Martin Barnes, Lorraine Farrell, Michael Tofano, Thuy Le Md, Andrew L. Silverman, Jacob Sokol, Albert Raminfard, Greg Haggerty, Vikas Kumar, and Himani Patel

Subjects
lcsh:Internal medicine, Quality management, business.industry, Task force, Psychological intervention, Heart failure, 030204 cardiovascular system & hematology, medicine.disease, Community hospital, quality improvement, readmissions, Teaching hospital, 03 medical and health sciences, 0302 clinical medicine, Internal Medicine, Medicine, 030212 general & internal medicine, Medical emergency, lcsh:RC31-1245, business, community hospital, Medicaid, Research Article
Abstract

In 2012, Centers for Medicare and Medicaid Services (CMS) announced it would penalize any hospitals that had 30-day readmission rates for heart failure (HF) patients above 20%. Mather Hospital Northwell Health, a community teaching hospital, organized a proactive task force to meet these goals. We describe our hospital-wide Readmission Prevention in Heart Failure (RAP-HF) project. We focused on the following interventions: early identification of patients at risk for readmission, discipline-specific mitigation planning by the interdisciplinary rounding team, enhanced medication education for heart failure patients, education of family/caregivers on medication and heart failure symptoms, facilitation in scheduling of post-discharge follow up visits and hard-wired communication between hospital and post-discharge care providers. We saw a 25.53% decrease in 30-day readmission rates.

Published
2020
Full Text
View/download PDF

4. LA inhalers for COPD: perceptions/reality of ABCD GOLD tool use

Author

Thuy Le Md, Joseph Ng, Vikas Kumar, Alan Kaell, Varvara Boryushkina, Haseeb Siddique, Shaha Nabeel, Martin Barnes, and Greg Haggerty

Subjects
lcsh:Internal medicine, COPD, medicine.medical_specialty, biology, business.industry, Brief Report, LAMA, LABA, 030204 cardiovascular system & hematology, Lama, medicine.disease, biology.organism_classification, Obstructive lung disease, GOLD criteria guidelines, respiratory tract diseases, 03 medical and health sciences, 0302 clinical medicine, Internal Medicine, medicine, 030212 general & internal medicine, lcsh:RC31-1245, Intensive care medicine, business, hormones, hormone substitutes, and hormone antagonists
Abstract

Background: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) created an ABCD tool to assess staging and severity of COPD subgroups that respond to LAMA or LABA with improved quality of life and reduced exacerbations. Our study assesses perception of physicians at five community hospitals towards LAMA use for patients admitted with COPD exacerbations according to the GOLD guidelines and describes the experience at our hospital. Methods: Electronic survey forms regarding LAMA use and the GOLD criteria ABCD for COPD treating physicians were sent to five hospitals. A one-year chart review at our hospital determined prevalent use of a maintenance LAMA or LABA inhaler in patients admitted with acute COPD exacerbation. Currently, our EMR does not require a field for the GOLD ABCD categorization. Results: We obtained a 33% (45/136) response rate. Of these, 63% felt a LAMA to be essential on formulary; 60% were neutral or unlikely to initiate LAMA on admission; 47.7% likely or very likely to start a LAMA during hospitalization; 82% were neutral to very likely to discharge a patient on a LAMA if deemed necessary for maintenance. Of those admitted for acute COPD exacerbations to our hospital, over a third of COPD patients were not on a maintenance LAMA or LABA. Conclusions: Most physicians felt it important to prescribe a maintenance LAMA to COPD patients hospitalized for acute exacerbation. Our hospital’s use of LAMA or LABA demonstrates the need to incorporate strategies to encourage appropriate prescribing of these LA inhalers per GOLD guidelines.

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results